Friday, 27 May, 2022
HomeCoronavirus Watch

Coronavirus Watch

WHO to investigate Eastern Cape’s high COVID-19 death rate

Experts from the World Health Organisation (WHO), accompanied by a team from the national health department, has started the probe into the Eastern Cape’s...

More than one in 10 COVID patients infected in hospital in UK's first wave

Prevention of hospital-acquired infections is a critical aspect of clinical management of COVID-19, as hospital-acquired infections have been a common feature of previous novel...

Cerebral venous thrombosis and the AstraZeneca vaccine — UK cohort study

The largest study yet of cerebral venous thrombosis after vaccination against COVID-19 (VITT), shows that those affected were younger, had fewer venous thrombosis risk...

Confronting America's next national health disaster: long-haul COVID-19

Now that more than half of all US adults have been vaccinated against SARS-CoV-2, masking and distancing mandates have been relaxed, and COVID-19 cases...

FDA committee endorses Pfizer-BioNTech vaccine for 5- to 11-year-olds

On Tuesday this week, the US Food and Drug Administration's vaccine advisory committee overwhelmingly endorsed a smaller dose of the Pfizer COVID-19 vaccine for...

Moderna interim results show that its low-dose vaccine works for 6-11-year-olds

A low dose of Moderna’s COVID-19 vaccine appears to be efficacious in 6- to 11-year-olds, says the manufacturer as it joins its rival Pfizer...

J&J vaccine: Booster jabs from Moderna or Pfizer might be better – NIH trial

People who received a Johnson & Johnson (J&J) coronavirus vaccine may be better off with a booster shot from Moderna or Pfizer-BioNTech, according to...

Interferon worse than placebo in severe COVID — US NIAID trial

Interferon beta-1a plus remdesivir (Veklury) was not superior to remdesivir alone in hospitalised patients with COVID-19 pneumonia. Patients who required high-flow oxygen had worse...

COVID herd immunity may be a family affair — Swedish cohort study

Family members without immunity had a 45% to 97% lower risk of contracting COVID-19 as the number of immune family members increased, found a...

Aspirin substantially lowers COVID risk — George Washington University study

Aspirin reduced the risk of mechanical ventilation by 44%, ICU admissions by 43%, and overall in-hospital mortality by 47%, found a George Washington University...

Obese COVID patients twice as likely to be admitted to ICU or die — Swedish cohort study

A Swedish cohort study determined that obese patients, (BMI >35 kg/m2), were twice as likely to experience a prolonged ICU stay or die, according...

Having flu at the same time as COVID doubles death risk — UK Health Security Agency

People who catch flu and COVID at the same time are twice as likely to die than those who only have coronavirus, found a...

Convalescent plasma fails to improve outcomes in critically ill COVID-19 patients

Convalescent plasma didn’t help adults with critical COVID-19 have better outcomes, according to a randomised trial published in JAMA. The 2,011-person study was rolled out...

Merck’s COVID antiviral pill may halve the risk of hospitalisation and death

Merck has announced that its experimental drug for severe COVID cuts the risk of hospitalisation or death by about half, according to interim clinical...

Delta variant increases COVID-19 risks for pregnant women

Compared to coronavirus cases earlier in the pandemic, infections with the Delta variant lead to worse outcomes for unvaccinated pregnant women, new data suggest. Doctors...

Pfizer vaccination ‘highly effective’ against Delta in adolescents — Israel study

The Pfizer-BioNTech COVID-19 vaccine (Comirnaty) was effective against the Delta variant among adolescents aged 12 to 15 in the month after vaccination, a case-control...

European Medicines Agency approves Pfizer booster for 18-years and older

The European Medicines Agency has approved the administering of booster shots of the Pfizer-BioNTech COVID-19 vaccine for people 18 and older. The EMA said the...

Pfizer/BioNTech vaccine antibodies gone in many by seven months — Small US study

Six months after receiving the second dose of the two-shot vaccine from Pfizer and BioNTech, many recipients no longer have vaccine-induced antibodies that can...

Pandemic triggers biggest fall in life expectancy in decades — 29-country study

The COVID-19 pandemic triggered significant mortality increases in 2020 of a magnitude not witnessed since World War II in Western Europe or the breakup...

Casirivimab–Imdevimab reduced hospitalisation of high-risk patients with mild to moderate COVID-19

Among high-risk patients with mild to moderate COVID-19, casirivimab–imdevimab treatment was associated with a significantly lower rate of hospitalisation, reports a Mayo Clinic study...

Plant-based diet associated with lower risk and severity of COVID-19

A plant-based diet was associated with lower risk and severity of COVID-19, particularly evident among individuals living in areas with higher socioeconomic deprivation, found...

Long COVID less common than previously estimated — UK National Statistics

One in 40 people with coronavirus has symptoms lasting at least three months, concludes the largest and most comprehensive analysis yet, by the UK...

Double vaccination cuts breakthrough infection risk substantially — King’s College London

In the unlikely event of catching COVID-19 after being double vaccinated, the risk of long COVID was reduced by almost half, found a study, in...

CDC: Unvaccinated people are 11 times more likely to die of COVID

Unvaccinated people are 11 times more likely to die from COVID-19 than those who are fully vaccinated, research has found, bolstering evidence that the...

CDC: Two-dose mRNA vaccines best at avoiding hospitalisations

In terms of preventing COVID-related hospitalisations, the two-dose mRNA vaccines from Pfizer (Comirnaty) and Moderna offered the best protection upfront and over time, a...

Remdesivir did not affect COVID-19 outcomes or mortality — DisCoVeRy trial

Remdesivir treatment did not significantly affect mortality, clinical outcomes, or time to improvement in patients hospitalised with severe COVID-19, found a study in The...

Pfizer/Moderna vaccine side effects in breastfeeding women and infants

Breastfeeding mothers who received either the Pfizer-BioNTech or Moderna vaccination reported the same local or systemic symptoms as previously reported in non-breastfeeding women, except...

Fully-vaccinated account for only 1.2% COVID deaths in England — Office of National Statistics

People who were fully vaccinated accounted for just 1.2% of all deaths involving COVID-19 in England in the first seven months of this year,...

Masks helped limit COVID transmission in unvaccinated students — US study

Masking, along with fewer exposure encounters, helped significantly to cut the incidence of COVID-19 infection among largely unvaccinated US university students. Among nearly 400 close...

SAHPRA: As yet, none of post-vaccination deaths caused by the jab

With just more than 12 million doses of COVID-19 vaccines already administered countrywide, the South African Health Products Regulatory Authority (SAHPRA) said during a...

Sputnik vaccine’s backers attack SAHPRA over emergency authorisation

SA’s medicines regulator has come under attack from the financial backers of the Russian COVID-19 vaccine Sputnik V, claiming its failure to grant the...

South African youngsters get their first jabs in Sinovac trials

Sinovac launched COVID-19 clinical trials for South African children aged from six months to 17 years old last Friday (10 September), with two 17-year-olds...

Public Health England: New COVID-19 variant detected in Colombia

A new coronavirus variant, known as B.1.621, and first detected in Colombia, has shown signs of evading the immune response triggered by either COVID-19...

Black American women with vitamin D insufficiency at increased COVID-19 risk

Black American women with low levels of vitamin D appeared are at increased incidence of COVID-19 infection, found research led by Boston University’s Slone...

Association between loss of smell in after SARS-CoV-2 infection and cognitive impairment

Older adults frequently suffer persistent cognitive impairment after recovery from SARS-CoV-2 infection and this is correlated with persistent loss of smell (anosmia), according to...

Neurological injury biomarkers in acute COVID-19 normalise in the long term – Swedish study

The normalisation of central nervous system (CNS) injury biomarkers in all individuals, regardless of previous disease severity or persisting neurological symptoms, indicates that post...

Full-dose Heparin reduced need for organ support in moderately ill COVID-19 patients

Full-dose blood thinners have been found to reduce the need for organ support in moderately ill COVID-19 patients, but not in critically ill patients,...

Previous COVID prevents Delta infection better than Pfizer shot — Israel study

Natural immunity confers longer lasting and stronger protection against infection, symptomatic disease and hospitalisation caused by the Delta variant of SARS-CoV-2, compared to Pfizer-BioNTech...

Effectiveness of Pfizer vaccine in pregnancy — Clalit Health Services study

The BioNTech-Pfizer vaccine has similar high vaccine effectiveness in pregnant women as to that in the general population, a study in Nature found. To evaluate...

Pfizer vaccination linked to 3x high risk of myocarditis — Israel study

The Pfizer COVID-19 mRNA vaccine was found to be associated with a threefold increased risk of myocarditis, according to a real-world case-control study from...